Who we are?

Home 5

Vertically integrated producer of high margin cannabis extracts and non-smokeable products for recreational, health & wellness and medicinal use

Home 5

International presence in the USA, Latam and Western Europe

Home 5

Global supply chain with low cost sourcing from Colombia

Home 5

Led by a team combining 50+ years of cannabis industry experience, regulatory know how and executive leadership of multinational public companies.

Home 5

Founded in 2016 and CF positive 12 months post launch

Home 5

All funding to date provided by founders, now raising a 10M USD Series A : 6M USD Colombia + 4M USD USA

Presence in markets with 800M population

Home 11

Our vision and strategy



Cultivation commoditizing

Shift to non-smokeable products

Blurring boundaries between medical, recreational and health

Emerging brands

Opening of international markets


Key success factors

Low cost and scale

Product innovation


Digital and social media marketing

In-depth local regulatory insight


Folium strategy

Low-cost Colombian cultivation

Oil, concentrates and MIPS focus

Different BUs
per end market

Experienced online marketing team

Local partnerships

Medical division:

Foliumed Bogotá, Colombia

Home 18


We started the application process for cultivation, extraction and export licences for psychoactive and non-psychoactive cannabis (CBD) in Q4 2017. Our decision to locate our medical division in Colombia has been based upon the country’s unique growing conditions, the availability of highly skilled human resources and a favorable, export- oriented regulatory framework.

Growth strategy

Following licence approval in Q3 2018, we will build out our 16 hectare cultivation and GMP extraction site in close proximity to Bogota. Our commercial strategy is to provide affordable, efficacy-proven prescription medicines and innovative OTC products to:

Home 19

Latin America 

a market with

625 M people

where high cost LPs won’t be able to compete.

Home 20

Major regulated import

markets such as

Germany or Canada

where demand outstrips supply

Facts and figures

Home 21

Total cultivation capacity:

77 tons

of dried flower per annum

Home 22

Total oil extraction capacity:

12 tons

of oil per annum

Adult use:

Strategic partnership with TapRoot Las Vegas, USA

Home 23

TapRoot is a Las Vegas-based producer of premium cannabis oils for leading brands

• Since start of operations in July 2017, we produced over 200,000 grams of cannabis extracts
• Primary focus on extraction – currently limited cultivation and propagation of proprietary genetics
• Exceptional quality: Our average THC content of 92%is well above industry average of 70%

We are expanding our currently limited footprint from 1,000 to 17,000 square feet

• Develop a 8,500 square foot cultivation space for cannabinoid specific health & wellness related products
•Increase oil production capacity to 2000 kg/p.a

• Enable production of branded flower, edibles and concentrates multiplying our accessible market by 10x
• Prepare facility for cGMP certification

We also are applying for additional licenses in Las Vegas

Participating in licensing process with applications for 8 Nevada dispensaries submitted

Facts and figures

Home 22

Oil production capacity post 2018 expansion:

2000 kg/p.a.

Home 25

BtoB market share:


Home 26

BtoB market share:


Home 27

Distribution reach:

25% of Nevada PoS

Our Products

Home 18

Medical Products

Home 29
Home 30
Home 31
Home 32

Adult Use Products

Home 33
Home 34
Home 35

Founder Team

Oliver Zugel

Co-founder and Chairman

    • Former CEO of multinational gaming companies in Europe and Latam
    • Increased EBITDA from 70 to 300 M Euros and prepared IPO for a 2 bn USD company
    • Background in strategy consulting and PE with Michael Porter’s Monitor Company
    • 1st Class Degree from the LSE

Shane Terry

CEO Taproot Nevada

  • Co-founder of Taproot and CEO of several US cannabis companies
  • Former President of Nevada Dispensary Association and Board Member of cannabis company GB Sciences
  • #1 Flight Commander in the US Air Force for over 130,000 personnel

Diego Felipe Navarro

Co-founder, CEO Colombia

  • Co-founder of FoliuMed Colombia
  • Former CEO of Codere Colombia & Panamá, the no. 2 gaming operator with 1,500 employees.
  • Industrial Engineering honors graduate of the Javeriana University in Bogotá, EMBA from Los Andes University in Bogotá. IE Business School.


CBD Testers – Will European Medical Cannabis Shift From Flowers To Oils?

FoliuMed, Oliver Zugel , Interview
Feb 9, 2020.

High Yield – Insights CBD Consumer Experience

FoliuMed Products
August 2019.

PR Newswire – Colombian Producer Foliumed Launches CBD sales in Europe.

FoliuMed, Oliver Zugel – Diego Navarro
Jul 18, 2019.

MJBiz – Changes in store for Colombia cannabis regulations, but final rules and timeline uncertain

Diego Navarro- FoliuMed, quoted.
Jul 05, 2019
Denver – USA

Contact us

[contact-form-7 id=”310″]